Literature DB >> 32817186

Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.

Phuong Hoang1, Brigitte Hurtubise2, Srikanth Muppidi2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32817186     DOI： 10.1212/WNL.0000000000010651

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

Review 1.  The relationship between myasthenia gravis and COVID-19: a systematic review.

Authors:  Dodik Tugasworo; Aditya Kurnianto; Yovita Andhitara; Rahmi Ardhini; Jethro Budiman
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2022-07-07

2.  Perspectives of Neuro-COVID: Myasthenia.

Authors:  Josef Finsterer; Fulvio A Scorza
Journal:  Front Neurol       Date:  2021-02-26       Impact factor: 4.003

Review 3.  Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.

Authors:  Giuliana Galassi; Alessandro Marchioni
Journal:  Acta Neurol Belg       Date:  2021-04-02       Impact factor: 2.396

Review 4.  Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.

Authors:  Saikat Dewanjee; Jayalakshmi Vallamkondu; Rajkumar Singh Kalra; Nagaprasad Puvvada; Ramesh Kandimalla; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2021-06-24       Impact factor: 5.590
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.